BioOra Limited and Cincinnati Children's today announced a strategic partnership to advance Atla-cel, (atlacabtagene autoleucel, pINN List 134), a third-generation CD19-directed CAR-T cell therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results